Dr. Rose is a Co-director for the Global Health track in the Master of Public Health Program and an Assistant Professor of Pediatrics in the Department of Pediatrics. Her professional passion lies at the intersection of education and health in helping others enhance their skill sets to lead their communities to improved health outcomes. Dr. Rose’s primary research focuses on capacity strengthening programs as well as research colonialism among academic biomedical researchers located in low- and middle-income countries. Working with colleagues in Africa and at the Vanderbilt Institute for Global Health, she designs evidence-based training programs in mentorship and curriculum development for medical school faculty. At Vanderbilt, Dr. Rose leads global health clinical rotation and research immersion courses for medical and public health students, and she recently helped start a global health program for residents across specialties.

Dr. Christian Rosas-Salazar is a pediatric pulmonologist and physician scientist with expertise in clinical and translational research. The main goal of his research is to identify pre-, peri-, and post-natal risk and protective factors for the development of common childhood respiratory diseases, including bronchiolitis and asthma. In particular, his current scientific program focuses on 1) examining genetic, environmental, sociodemographic, and lifestyle factors that shape the early-life respiratory microbiome, 2) evaluating the role of the early-life respiratory microbiome in the programming of the immune response, the severity of acute viral respiratory infections in infancy, and the origins of pediatric asthma phenotypes, and 3) developing novel interventions to manipulate the early-life respiratory microbiome with the ultimate purpose of preventing acute and chronic lung diseases in children.

Dr. Rosas-Salazar’s multidisciplinary team leverages a broad range of knowledge spanning the fields of epidemiology, microbial ecology, multi-omics, infectious diseases, and pediatric pulmonary medicine. His group uses a combination of patient-oriented research, next-generation sequencing, high-throughput immunoassays, novel bioinformatics, and other state-of-the-art technologies to continue to advance our understanding of the determinants of childhood respiratory health.

Dr. Rosas-Salazar’s prior studies have been published in some of the most important scientific journals, including The Lancet, The American Journal of Respiratory and Critical Care Medicine, The Journal of Allergy and Clinical Immunology, Chest, Thorax, and The Journal of Infectious Diseases. His scientific program has been supported by funds from the Parker B. Francis Fellowship; Vanderbilt University Medical Center; the National Institute of Allergy and Infectious Diseases; the National Heart, Lung, and Blood Institute; and the Environmental Influences on Child Health Outcomes of the National Institutes of Health. Furthermore, his contributions to research have been recognized by honors from the American Thoracic Society, the American College of Chest Physicians, the Society for Pediatric Research, and the Delta Omega Honorary Society in Public Health, among others.

>> View Publications on PubMed

Dr. Rohrbough investigates the ion transport properties of the ClC-3 2 Cl-/1 H exchanger and the LRRC8 (VRAC) chloride channel, and developmental chloride conductances in the ductus arteriosus. He uses electrophysiological recordings (whole cell, perforated patch and intracellular recordings), confocal microscopy, and optical cellular recording of intracellular Cl- and pH. Dr. Rohrbough received his training in Neuroscience at the University of California Los Angeles. His earlier work focused largely on synaptic development, including the functional development of voltage-gated ion channels and multiple classes of synaptic transmitter receptors (GluR, GABAR, AChR) in vertebrate spinal neurons, and the development and genetic regulation of glutamatergic synaptic function in Drosophila.

Dr. Reising is a licensed clinical psychologist who specializes in psychosocial intervention for youth with serious health conditions and their families. Her research is clinical intervention based with a focus on stress, trauma, coping, and quality improvement regarding patient-centered care. In collaboration with clinical psychologist, Dr. Shari Neul, Dr. Reising co-created the Behavioral Hematology-Oncology Program (BHOP). BHOP program development focuses on providing evidence-based practices in the psychosocial assessment and support of youth diagnosed with cancer or hematological disorders and their families. Dr. Reising’s work is focused on development of an evidence-based psychosocial screening program with newly diagnosed oncology patients and their families, including the use of the Psychosocial Assessment Tool-2 (Pai et al., 2008). In collaboration with the Sickle Cell Disease (SCD) Team and Dr. Neul, Dr. Reising is incorporating an evidence-based cognitive screening, to aide in academic support planning and education of patients, families, and school personnel regarding the impact of SCD on learning and to ensure appropriate supports are in place to optimize academic and psychosocial functioning. Additionally, Drs. Reising and Neul are implementing quality improvement processes to improve access to psychosocial supports for patients with SCD and their families. Dr. Reising's quality improvement and program development efforts aim to provide evidence-based psychosocial assessment and intervention individually tailored to patient and family needs to optimize psychological adjustment and health outcomes.